These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 31714814

  • 21. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
    Chang FC, Kwan V, van der Poorten D, Mahant N, Wolfe N, Ha AD, Griffith JM, Tsui D, Kim SD, Fung VS.
    J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment.
    Matsuyama H, Matsuura K, Ishikawa H, Hirata Y, Kato N, Niwa A, Narita Y, Tomimoto H.
    Brain Behav; 2018 Dec; 8(12):e01143. PubMed ID: 30358126
    [Abstract] [Full Text] [Related]

  • 28. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
    Zibetti M, Rizzone M, Merola A, Angrisano S, Rizzi L, Montanaro E, Cicolin A, Lopiano L.
    Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
    [Abstract] [Full Text] [Related]

  • 29. Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.
    Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P, GLORIA study co-investigators.
    Parkinsonism Relat Disord; 2017 Dec; 45():13-20. PubMed ID: 29037498
    [Abstract] [Full Text] [Related]

  • 30. [Levodopa-carbidopa intestinal gel treatment introduced by surgical gastrostomy in a patient of Parkinson's disease after Billroth II gastrojejunostomy].
    Nakano T, Hirozawa D, Shimamura M, Sasaki T, Ikenaka K, Mochizuki H.
    Rinsho Shinkeigaku; 2018 Sep 28; 58(9):570-573. PubMed ID: 30175807
    [Abstract] [Full Text] [Related]

  • 31. Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study.
    Senek M, Nielsen EI, Nyholm D.
    Mov Disord; 2017 Feb 28; 32(2):283-286. PubMed ID: 27987231
    [Abstract] [Full Text] [Related]

  • 32. Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy.
    Loens S, Chorbadzhieva E, Kleimann A, Dressler D, Schrader C.
    Brain Behav; 2017 May 28; 7(5):e00698. PubMed ID: 28523235
    [Abstract] [Full Text] [Related]

  • 33. Improvement of dyskinesias with L-dopa infusion in advanced Parkinson's disease.
    Timpka J, Fox T, Fox K, Honig H, Odin P, Martinez-Martin P, Antonini A, Chaudhuri KR.
    Acta Neurol Scand; 2016 Jun 28; 133(6):451-8. PubMed ID: 26358227
    [Abstract] [Full Text] [Related]

  • 34. Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.
    Buhmann C, Hilker R, Lingor P, Schrader C, Schwarz J, Wolz M, Reichmann H.
    J Neural Transm (Vienna); 2017 Aug 28; 124(8):1005-1013. PubMed ID: 28229223
    [Abstract] [Full Text] [Related]

  • 35. Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease.
    Zibetti M, Angrisano S, Dematteis F, Artusi CA, Romagnolo A, Merola A, Lopiano L.
    J Neurol Sci; 2018 Feb 15; 385():105-108. PubMed ID: 29406886
    [Abstract] [Full Text] [Related]

  • 36. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
    Antonini A, Yegin A, Preda C, Bergmann L, Poewe W, GLORIA study investigators and coordinators.
    Parkinsonism Relat Disord; 2015 Mar 15; 21(3):231-5. PubMed ID: 25585993
    [Abstract] [Full Text] [Related]

  • 37. Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion.
    Imbalzano G, Artusi CA, Ledda C, Montanaro E, Romagnolo A, Rizzone MG, Bozzali M, Lopiano L, Zibetti M.
    J Parkinsons Dis; 2024 Mar 15; 14(4):843-853. PubMed ID: 38728203
    [Abstract] [Full Text] [Related]

  • 38. [Levodopa-carbidopa intestinal gel in the treatment of patients with Parkinson disease: results of a 12-month open study].
    Skoromets AA, Odinak MM, Yakupov EZ, Litvinenko IV, Zalyalova ZA, Timofeeva AA, Kirtaev SY, Bogdanov RR, Agafina AS, Chatamra K, Robieson W, Benesh J, Latypova GR, Ershova MV, Illarioshkin SN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017 Mar 15; 117(2):22-31. PubMed ID: 28374689
    [Abstract] [Full Text] [Related]

  • 39. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study.
    Juhász A, Aschermann Z, Ács P, Janszky J, Kovács M, Makkos A, Harmat M, Tényi D, Karádi K, Komoly S, Takáts A, Tóth A, Nagy H, Klivényi P, Dibó G, Dézsi L, Zádori D, Annus Á, Vécsei L, Varannai L, Kovács N.
    Parkinsonism Relat Disord; 2017 Apr 15; 37():79-86. PubMed ID: 28185758
    [Abstract] [Full Text] [Related]

  • 40. Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease.
    Meloni M, Solla P, Mascia MM, Marrosu F, Cannas A.
    Parkinsonism Relat Disord; 2017 Apr 15; 37():92-96. PubMed ID: 28063683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.